Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2013 Third Quarter Financial and Business Results
Date:8/6/2013

or the same period in fiscal 2012.

Fiscal 2013 Nine-Month Results

  • Total net revenues for the first nine-months of fiscal 2013 totaled $53.7 million, compared with $27.7 million for the first nine-months of fiscal 2012.
  • Total operating expenses were $90.6 million in the first nine-months of fiscal 2013, compared to $75.5 million in the comparable period for fiscal 2012.
  • Cash used in operations was $35.3 million in the first nine-months of fiscal 2013.
  • Net loss for the first nine-months of fiscal 2013 was $40.0 million, or $0.29 per share, compared with a net loss of $48.0 million, or $0.36 per share for the comparable period in fiscal 2012.
  • NUEDEXTA RevenueFor the quarter ended June 30, 2013, the company reported NUEDEXTA gross and net revenue of $24.3 million and $19.0 million respectively. Third quarter fiscal 2013 NUEDEXTA net revenue increased 89% versus the previous year and 15% over the previous quarter.

    Cash, Cash Equivalents & Marketable SecuritiesAs of June 30, 2013 Avanir had cash, cash equivalents and restricted investments totaling $57.5 million, including cash and cash equivalents of $55.0 million.

    Business Highlights

  • The company reported 27% unit growth of NUEDEXTA representing the ninth consecutive quarter of double-digit growth.
  • The U.S. Food and Drug Administration (FDA) agreed to an expedited development pathway for the company's next-generation compound, AVP-786, requiring only a limited pre-clinical package as part of the Investigational New Drug (IND) application. Upon completion of these pre-clinical studies the company intends to proceed directly into human clinical trials.
  • The European Commission approved NUEDEXTA in the European Union for the treatment of pseudobulbar affect (PBA), irrespective of underlying neurologic disease or injury.
  • The company completed patient enrollment of PRIME, its phase II, placebo controlled study testi
    '/>"/>

  • SOURCE Avanir Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Avanir Pharmaceuticals to Participate in Two Conferences in August
    2. Avanir Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    3. Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA
    4. Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences
    5. Avanir Pharmaceuticals Reports Fiscal 2013 Second Quarter Financial and Business Results
    6. Avanir Pharmaceuticals Announces Date of Fiscal 2013 Second Quarter Financial Results and Conference Call
    7. Avanir Pharmaceuticals Receives Positive CHMP Opinion for Approval of NUEDEXTA in Europe
    8. AVANIR PHARMACEUTICALS ANNOUNCES RESEARCH COLLABORATION WITH DEPARTMENT OF VETERANS AFFAIRS FOR SCREENING PSEUDOBULBAR AFFECT (PBA) SYMPTOMS IN VETERANS WITH TRAUMATIC BRAIN INJURY
    9. AVANIR Pharmaceuticals To paticipate in two conferences in March
    10. Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
    11. Avanir Pharmaceuticals Announces Positive Interim Data From Pharmacokinetic Study With Next Generation Compound AVP-786
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/18/2014)... 18, 2014   MacPractice,s MacPractice MD MU ... EHR certification, which designates that the software is capable ... and Stage 2 Meaningful Use measures required to qualify ... (ARRA).  MacPractice MD MU version 5.0 was certified on ... Office of the National Coordinator-Authorized Certification Body (ONC-ACB) and ...
    (Date:9/18/2014)... , Sept. 18, 2014 Research and ... "China PTCA Balloon Market Investment Report, 2014-2016" report ... a indispensable medical device in percutaneous coronary intervention (PCI), ... but also as a device for pre-/post-stent dilatations. Therefore, ... to that of PCI. As national economy ...
    (Date:9/18/2014)... SAN FRANCISCO , Sept. 18, 2014   ... it has secured an initial seed round of funding. ... initial investments, was led by a series of individual ... the investors whom participated in the initial round are; ... Yampa Valley Medical Center Urologist Stacy Childs, Rapha Family ...
    Breaking Medicine Technology:MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5China PTCA Balloon Market Investment Report, 2014-2016 2China PTCA Balloon Market Investment Report, 2014-2016 3Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3
    ... 2011 Reportlinker.com announces that a new market ... Analytical Tool - Antibodies and Peptides ... "Analytical Tool – Antibodies and Peptides ... the vast amount of strategic possibilities that have ...
    ... 9, 2011 Reportlinker.com announces that a new ... Cetuximab - Comprehensive patent search ... Eliminate unnecessary risk with the industry benchmark ... is a regularly updated, professional patent search performed ...
    Cached Medicine Technology:Reportlinker Adds Analytical Tool - Antibodies and Peptides in Oncology 2Reportlinker Adds Analytical Tool - Antibodies and Peptides in Oncology 3Reportlinker Adds Cetuximab - Comprehensive patent search 2Reportlinker Adds Cetuximab - Comprehensive patent search 3Reportlinker Adds Cetuximab - Comprehensive patent search 4
    (Date:9/18/2014)... proven it true: exercise is good for you. But ... exercise may have an added benefit for cancer patients ... model of melanoma, found that combining exercise with chemotherapy ... Libonati, an associate professor in the School of Nursing ... Nursing Research, was the senior author on the study, ...
    (Date:9/18/2014)... Lambertville, NJ (PRWEB) September 18, 2014 ... consulting firm, announced today that President and co-founder ... Business Journal’s Innovation Award Winners for 2014, recognizing ... naming him as an emerging executive of the ... health care and life sciences that continue to ...
    (Date:9/18/2014)... Ben Quirk, CEO of Quirk Healthcare ... Award by the Savannah Science Seminar in recognition for ... the nation and especially in Savannah. , “I am ... “The Savannah Science Seminar is an amazing program that ... have gone through the program,” he added. Eleventh graders ...
    (Date:9/18/2014)... group of international scientists have developed a new method ... here . , The Wildlife Conservation Society (WCS)-led research, ... Diseases , describes the use of fecal samples from ... been exposed to the virus. This represents a new ... potentially change the way Ebola virus is studied and ...
    (Date:9/18/2014)... The National Institutes of Health (NIH) recently awarded ... million grant to the Los Angeles Biomedical Research Institute ... of a vaccine to protect patients from the healthcare-related ... (MRSA). , The National Institute of Allergy ... grant to LA BioMed infectious disease specialists John E. ...
    Breaking Medicine News(10 mins):Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2Health News:TayganPoint Executive Receives Prestigious Award from Philadelphia Business Journal 2Health News:Quirk Awarded the Alex Ormond, Jr. Leadership Award by the Savannah Science Seminar 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 2Health News:Research yields a game changer for improving understanding of Ebola and great apes 3Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2
    ... ... outcomes reporting to monitor the impact of expected health improvements as it translates toward ... , ... Jacksonville, FL (PRWEB) December 17, 2009 -- HealthScreen Disease Management, an independent health risk ...
    ... , BERKELEY, Calif., Dec. 17 If proposed ... in the employer-based insurance system. Approximately 18.4 million Californians and ... employer-based insurance for their health care coverage. , Both ... for employer-based insurance. While the vast majority of employees ...
    ... Gala Raises Significant Funds to Benefit of Children with Autism and ... and Zachary Levi Join Ben Stiller to Ring in the Holiday ... annual Teddy Bear Ball, The Help Group honored three remarkable individuals. ... the Help Humanitarian Award in recognition of his far-reaching ...
    ... , NORCROSS, Ga., Dec. 16 Immucor, Inc. (Nasdaq: ... systems to the blood transfusion industry, today announced that Paul ... a new independent director, effective January 1, 2010. , ... medicine for more than 30 years. He is a tenured ...
    ... ... embryonic stem cell lines lack genetic diversity, a finding that raises ... sectors of society benefit from stem cell advances, according to a ... of its kind, the U-M team analyzed 47 embryonic stem cell ...
    ... that increase susceptibility to disease , WEDNESDAY, Dec. 16 ... to leprosy have been identified by scientists in Singapore ... 10,000 DNA samples from leprosy patients and healthy people ... that the innate immune response plays in the development ...
    Cached Medicine News:Health News:Baptist Health System Selects HealthScreen Disease Management for Employee Health Management Services 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 2Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 3Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 4Health News:The Help Group Honors Brian Goldner, Mary Urquhart and Max Mayer at its Teddy Bear Ball Featuring Ben Stiller and Celebrity Guests 5Health News:Immucor Appoints New Board Director 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:Leprosy Genes Identified 2
    Inquire...
    ... The new GUCCI DONNA eyewear collection ... house,incorporating, with a vintage yet contemporary feel, ... leader., The new GUCCI UOMO optical and ... is,presented in classic lines with cutting-edge design ...
    Inquire...
    ... art software package designed to assist in the ... a lens manufacturer with years of experience in ... designed to help you run your lab the ... software dictates., ,Designed specifically for integrated retail and ...
    Medicine Products: